References
- World Health Organisation. Medicines and health products. [Internet]. Geneva: World Health Organization, 2012. Available from: https://www.who.int/healthsystems/topics/medicines/en/ Accessed 28 Oct 2019.
- Funestrand, H., Liu, R., Lundin, S. and Trocin, M. 2018. Substandard and falsified medical products are a global health threat. A pilot survey of awareness among physicians in Sweden. Journal of Public Health. Vol 41, No 1, pp e95-e102. doi: 10.1093/Pubmed/fdy092/ Advance Access Publication June 1, 2018.
- World Health Organization. 1 in 10 medical products in developing countries is substandard or falsified. [Internet]. Geneva: World Health Organization, Available from: https://www.who.int/news-room/detail/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified.
- World Health Organization. Substandard and falsified (SF) medical products [Internet]. Geneva: World Health Organization, Available from: https://www.who.int/medicines/regulation/ssffc/en/ Accessed 28 Oct 2019.
- A study on the public health and socioeconomic impact of substandard and falsified medical products. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Available from https://creativecommons.org/licences/by-nc-sa/3.0/igo.
- WHO Global Surveillance and Monitoring System for Substandard and Falsified Products. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Available from https://creativecommons.org/licences/by-nc-sa/3.0/igo.
- Baseline assessment of the Pharmaceutical Situation in Southern African Development Community countries. World Health Organization.In:Fact Book; 2009.
- Schiavetti B, Wynendaele E, Spiegeleer BD, Mbinze GJ, Kalenda N, Marini R, Meleotte V, Hasker E, Meessen B, Ravinetto R, Van de Elst J, Ngeleka DM. The quality of medicines used in children and supplied by private pharmaceutical wholesalers in Kinshasa, Democratic Republic of Congo: a prospective survey. Am J Tropical Med. 2017.
- Falsified medicines in Africa: all talk, no action. Correspondence article. The Lancet. Vol 2, September 2014.
- ACTWatch Group, Newton PN, HansonK, GoodmanKDo anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries. Malar J. 2017;16:204.
- https://www.who.int/medicines/publications/drugalerts/en/ Accessed 26 Aug 2020.
- Vorrath J, Voss M. The hidden dangers of falsified and substandard medicines. Developing countries are most affected by the illicit trade. SWP Comment. No. 2019:25.